Talking Biotech with Dr. Kevin Folta

The role of Cas9 as an editing/deletion nuclease has been well established, but can it be used to turn genes on?   Dr. Yiping Qi of the University of Maryland has developed a system where Cas9’s specificity is used to recruit gene expression activation factors to plant promoters.  The approach allows activation of sets of genes associated with disease resistance or other useful plant traits.

Show Notes

 The role of Cas9 as an editing/deletion nuclease has been well established, but can it be used to turn genes on?   Dr. Yiping Qi of the University of Maryland has developed a system where Cas9’s specificity is used to recruit gene expression activation factors to plant promoters.  The approach allows activation of sets of genes associated with disease resistance or other useful plant traits.

# COLABRA
Talking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/

# TALKING BIOTECH
Twitter: https://twitter.com/talkingbiotech
Website: https://www.colabra.app/podcasts/talking-biotech/
Instagram: https://www.instagram.com/colabrahq

The Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.

What is Talking Biotech with Dr. Kevin Folta?

Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering.

Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050.

Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.